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Introduction
Here, we describe how an iterative design process can change the metalloporphyrin specificity of cytochrome b562 (cyt b562), a b-type haem binding protein unit, from iron to fluorogenic and photochemically active zinc. Metalloporphyrins 1 represent an important class of organometallic compounds and play a major role in biology as essential supplements to enable protein function in processes ranging from light harvesting to electron transport to enzyme catalysis to O2 transport 2 . Binding to a protein tunes and modulates the metalloporphyrin physiochemical properties. The metal centres used in biology are Fe (e.g. haem), Mg (e.g. chlorophyll) and, to a much lesser extent Co (Vitamin B12) and Ni (F430). This does not however represent the full metal repertoire available to porphyrins (e.g. Cu, Pt, Ag, Cd, Ir, Zn) 1 . There is currently great interest in incorporating new metal cofactors into proteins. Such abiotic cofactors have recently been shown to confer new enzymatic catalytic routes [3] [4] . Zinc porphyrins such as zinc protoporphyrin IX (ZnPP, Figure 1a ) are one such class, playing important roles in clinical (including cancer therapy) and nanoscience settings. While ZnPP is not naturally utilised in biology as a protein cofactor, its aberrant presence in blood is commonly used to diagnose haem metabolism disorders 5 . The photo-induced electron and energy transfer properties of zinc porphyrins make them particularly attractive for nanoscale applications, ranging from photosensitizers in solar cells to molecular optoelectronic components [6] [7] [8] [9] . ZnPP is inherently fluorescent but substantially quenched in aqueous solution [10] [11] . Designer protein components have the potential to further enhance ZnPP use through: (i) activation of fluorogenic properties 12 in aqueous conditions as an aid to clinical sensing and cell imaging; (ii) providing an organised, defined and tunable selfassembling scaffold for nanodevice construction 6, [13] [14] [15] [16] [17] .
ZnPP incorporation within a protein scaffold has classically been achieved by either:
(i) metal centre exchange (in the case of covalently attached porphyrins) that require harsh conditions unsuitable for most biological settings 13, [18] [19] ; (ii) facile exchange in the case of non-covalent porphyrin-protein complexes 11, 20 . With regards to the latter, affinity for ZnPP is inherently low (Table S1) , with preference for the original haem cofactor; little attention is paid to optimising the protein interaction despite the structural and physicochemical variations on exchanging the porphyrin metal centre (Fig 1a) . Here we show how computational design can be used to switch cyt b562 specificity from its normal iron porphyrin (haem) to zinc. The new protein can activate ZnPP fluorescence both in vitro and in vivo. 
Results and discussion
Cyt b562 ( Figure S1 ) is a small, helical bundle protein that binds haem non-covalently [22] [23] [24] . It is an important model for electron transfer [25] [26] [27] [28] , engineering novel components [29] [30] [31] [32] [33] [34] and assembling supramolecular structures 6, 14, 35 . ZnPP can replace haem through passive exchange 20, 33, 36 but the environment is non-ideal resulting in relatively low affinity binding (404 nM ±11 KD; Table S1 ) and a significant background haem binding in vivo (Figure 1 ). Factors include non-optimal metal coordination ligands and change in tetrapyrole structure and planarity due to the larger ionic radius of Zn 2+ (Fig 1a) [37] [38] .
The first stage in the design process was to optimise Zn coordination. Zn coordination is normally through soft ligands such as the cysteine thiol group and the imidazole group of histidine, or base ligands from the carboxylate groups of aspartate and glutamate; the native M7 S-methyl thioether group is not an ideal axial ligand. This was confirmed through computational analysis with cysteine considered
the best, albeit still relatively poor, alternative (the M7C mutation). The second native axial ligand, the imidazole group of H102, was considered optimal so was not changed. The M7C variant was generated and the measured ZnPP and haem affinity (dissociation constant, KD) were comparable (181 ±11 nM for ZnPP and 206 ±2 nM for haem; Table S1 ) so generating a starting mutant with slightly improved ZnPP binding and lower haem affinity. Replacement of Met7 with either His (a second potential coordinating ligand) or Gly lowered ZnPP binding affinity to that of wild-type cyt b562 with the bis-His mutant retaining specificity for haem (Table S2 ).
The absorbance spectrum of cyt b562 M7C ( Fig S4) confirms ZnPP binding to the protein as indicated by the red shift in the Soret peak at 418nm for free ZnPP to a sharper peak at 431nm. The Soret and α/β band peaks of cyt b562 M7C are slightly blue shifted (8-10 nm) compared to the ZnPP bound to wild-type cyt b562. The Soret peak is also broader for wt cyt b562 suggesting a mixed binding population compared to cyt b562 M7C . The ZnPP α/β peaks ratio also switches on cyt b562 binding.
To further optimise ZnPP binding, a more systematic in silico mutagenesis approach was adopted. Using the wt holo cyt b562 crystal structure 39 as a starting point, every residue from 1 to 20 was replaced to every possible residue and energy minimised to avoid clashes. The structures derived from the energy minimisation were used as the starting point for docking simulations using AutoDock 40 and Rosetta LigandDock 41 .
As a test for the accuracy, the in silico derived binding energy of the wt cyt was compared with the measured KD. The measured binding energy for wt cyt b562 (where ∆G=RT lnKD) is -8.7 kcalmol -1 for ZnPP, and -11 kcalmol -1 and for haem.
These are close to the binding energies predicted from our modelling approach (Table S1 ). The in silico design process identified a variant with improved ZnPP binding energies termed cyt b562 ZnPP . In addition to the M7C mutation, four other mutations were identified (L3K, E4D, T9C, L10R). The affinity of variant for ZnPP was much lower (<10 nM) compared to wt cyt b562 (Table S1 and Figure S3 ) with minimal haem binding observed both in vivo ( Figure 1d ) and in vitro ( Figure S3a ).
This represents a near total switch in specificity from haem to ZnPP. The lowest scoring models were chosen for verification with Rosetta LigandDock, followed by molecular dynamics for 2 ns to ensure that the shape of the binding pocket was accurate. There was no significant change in the shape of the binding pocket when comparing before and after the molecular dynamics run. Residue 10 lies arose in the later stages of the design and buried in the holo form of the protein (Fig 1c) so it was surprising that not only was the L10R mutation tolerated but improved binding.
Mutating residue 10 to either alanine or serine reduced affinity to >100 nM. Analysis of the model suggests that the guanidinium group of R10 lies within 2-3 Å of the C7 thiol group (Fig 1c and S4) ; proton abstraction by R10 may generate a thiolate group, which is a better ligand for Zn binding than the C7 thiol. Cyt b562 ZnPP was analysed in more detail.
Cyt b562 ZnPP had a characteristic absorbance spectrum indicative of formation of ZnPP holo protein (Fig 2a) , with an extinction coefficient of 158 mM cm -1 at 424 nm, 5 nm blue shifted compared to wt cyt b562. On binding cyt b562 ZnPP , ZnPP fluorescence intensity increased >60 fold (Fig 2b) . Excitation at 431 nm gave the expected dual peak emission characteristic of ZnPP 19 (λEM 590 and 640 nm) with a Stoke's shift of 160 nm and 210 nm (Fig 2b) . The peak ratio of the two emission peaks was circa 2:1 (590:640 nm). Protein-bound ZnPP could be excited at 431 nm, 550nm and 590 nm ( Fig S5) . While the brightest emission originated from excitation at 431 nm the ability to excite at multiple and longer wavelengths has obvious benefits for biological imaging. These fluorescence characteristics were observed for wt cyt b562 and cyt b562 M7C ( Fig S6) suggesting that the mutations affected only binding affinity. The quantum yield for the combined emission peaks was measured to be ~92% generating a protein with a brightness of 146 mM -1 cm -1 , higher than many autofluorescent proteins [42] [43] [44] . ZnPP fluorescence is quenched in aqueous solutions to the extent that the quantum yield could not be accurately measured Coupled with the fluorogenic properties, cyt b562 ZnPP could make a useful genetically encoded imaging agent. A prerequisite for cell imaging is that ZnPP should pass through membranes and have no significant fluorescence in the cell until it binds specifically to cyt b562 ZnPP . E. coli cells expressing cyt b562 ZnPP were colourless in comparison to those expressing wt cyt b562 (Figure 1d ), which are a pink-red hue due to binding available haem with high affinity 31 . This confirms cyt b562 ZnPP reduced affinity for haem and thus a decreased capacity to bind endogenous haem compared to the wt cyt b562. On addition of ZnPP to E. coli cells expressing cyt b562 ZnPP50 , fluorescence increased over time until plateauing after ~40-50 min (Fig 2c) . Cells with no plasmid-encoded cyt b562 exhibited low baseline fluorescence on addition of ZnPP, which remained steady over the course of the incubation. Red edge excitation shift (REES) analysis was performed to ascertain the effect of ZnPP binding to cyt b562 ZnPP (Fig 3a) . REES is an optical phenomenon where decreasing the excitation energy (increasing the excitation wavelength, EX) gives rise to a red shift in the maximum of the fluorescence emission ( EM). Such shifts can arise where the fluorophore exists in a range of discrete solvation environments that are sampled as part of an equilibrium of solvent-solute interaction energies 45 . In some cases, decreasing the energy of excitation allows for photo-selection of the discrete states that are red shifted (lower energy). We have recently demonstrated that for a single fluorophore (tryptophan) containing protein, the REES effect can inform on the equilibrium of conformational states accessible to the fluorophore 46 .
The REES data for free and protein-bound ZnPP are shown in Figure 3a and have been extracted for the α/β emission maximum shown in Figure 2b , EM-1 and EM-2, respectively. Free ZnPP exhibits a significant REES effect that is reduced on binding to cyt b562 ZnPP ; the change in EM-1 and EM-2 respectively being 0.56 ± 0.02 nm -1 and 0.21 ± 0.02 nm -1 for free ZnPP, which reduces to 0.12 ± 0.01 nm -1 and -0.04 ± 0.03 nm -1 on binding cyt b562 ZnPP50 . These data therefore suggest that the free ZnPP exists in an equilibrium of discrete solvation states and that this equilibrium collapses to essentially a single state on binding to the protein. These data therefore suggest tight ZnPP binding within the core of the protein, with limited solvent access, akin to haem binding. To further confirm ZnPP binding to cyt b562 ZnPP , CD spectroscopy was used to monitor the expected transition from a partially folded helical structure to a folded 4-helix bundle on co-factor binding. On addition of ZnPP to cyt b562 ZnPP , the deepening of troughs at ~208 nm and 222 nm was observed confirming the increase in helical character, with the spectra of holo-cyt b562 ZnPP50 similar to that observed for wt holo-cyt b562 (Fig 3b) .
Using systematic computationally guided engineering, the metalloporphyrin specificity of cyt b562 can be switched to ZnPP; the affinity is on a par with the natural haem cofactor and represented a near total switch in specificity. A fluorogenic effect was observed generating a protein complex with high brightness that exceeds that of many autofluorescent proteins. Higher affinity and thus more stable binding make holo-cyt b562 ZnPP50 a more useful photo-electronic nanodevice 15, 33 ; a protein scaffold can also tune facets such as electronic excitation and emission. More generally, it provides a route for improving affinity of various different haemoproteins for ZnPP and other metalloporphyrins, in which the haem can be replaced by the photosensitizer effect of ZnPP 13, 47 or the catalytic properties of Ir and Cu porphyrins [3] [4] . The design process has shown changing metal coordinating ligands is not the defining step but that optimising residues adjacent to the metal coordination site is critical to success. 
Switching metalloporphyrin binding specificity of a b-type

In silico design. ZincExplorer
In silico protein design was performed by initially using the native wild-type cyt b562 sequence with the ZincExplorer web server 48 (http://protein.cau.edu.cn/ZincExplorer). Successive mutations were assessed by selecting existing residues, replacing them and resubmitting them to the server. The relative scores returned from the server were used to determine if a mutation was likely to improve Zinc protoporphyrin IX (ZnPP) binding (see Figure S1 ). The first design phase focused on replacing the M7 co-ordinating residue with alternatives to identify a better potential axial ligand residue. The second design round built on the best scoring variant from the first round introduced secondary mutations around residue 7.
Mutant Modelling Using the published crystal structure of wild type cyt b562 (PDB:256B 24 ) as a starting point, in silico mutagenesis was performed using the mutagenesis application within MacPyMol 49 to change a single residue to another. This process was automated using shell scripts to allow for the creation of a library of structure files that replaced residue 1-20 with every other possible residue. Each initial model was used as the starting point and energy minimised to avoid any clashes caused by the mutation introduction. The starting structure was then placed within a triclinic box with dimension of 6.4x6.1x7.8 nm. This was populated using the Simple Point Charge (SPC) water model 50 to solvate the system to a total number of 16986 solvent molecules. The system was first energy minimised by performing 500 steps of steepest descent method followed by 500 steps of conjugant gradient method. The lowest energy state of the system was used as the starting conformation for the docking simulations.
Ligand Docking with AutoDock Structure files for ZnPP were made using Avogadro 51 . Geometry optimization calculations were performed using GAMESS-US 21 at the HF/6-31G* level in order to be consistent with the AMBER99sb force field 52 . The optimised structure was used as the ligand file during docking simulations. The standard AutoDock4 40 protocol was used as described in the software documentation. The scripts prepare_receptor4, prepare_ligand4, prepare_gpf4, prepare_dpf42 and prepare_flexreceptor4 (distributed with the software) were used to prepare the energy minimised mutated structure files for docking. For each variant 50 models were made and the lowest 5% of the predicted free binding energies were taken and averaged to give an approximate score for each mutation, these were then ranked and the lowest scoring mutant was chosen as the starting point for another round of mutations.
Ligand Docking with Rosetta LigandDock The five lowest scoring variants from the AutoDock docking simulations for each round were chosen to be confirmed using the Rosetta LigandDock program 41 . Docking was carried out using the Automatic RosettaLigand Setup script supplied with the program. The predicted binding energies and Rosetta score were compared with the results from the AutoDock docking analysis to inform the choice of which mutation would be used as the starting point of the next round of mutations.
Cyt b562 mutagenesis and protein production. Construction of cyt b562 ZnPP variants described in this paper was performed using site directed mutagenesis, essentially as outlined previously 30 . Cyt b562 and its variants were expressed and purified as outlined previously 30 .
When required, purified cyt b562 was converted to apo-form before ZnPP replacement by using organic solvent extraction approach 31 . The proteins were buffer exchanged into water and the pH lowered to 1.5 before mixing with ice-cold 2butanone. The mixture was then centrifuged for 2 minutes at 13,000x rpm in a bench top microfuge. The organic phase was removed and the preceding steps were repeated 5 times. The pH was returned to pH 6 before buffer exchanging back into 10mM Tris buffer.
ZnPP and hemin was purchased from Sigma Aldrich. The molecules were dissolved in 1 M NaOH prior to use to a final ZnPP concentration of 1 mM. ZnPP was stored in the dark at 4 C and centrifuged prior to use in experiments to prevent molecular aggregation and photodegradation. The ZnPP solution was then added to 10 mM Tris buffer to a final concentration of 200 µM. This was then added to a solution of 100 µM apo-cyt b562 in 10 mM Tris buffer and incubated for 12 hours at 25°C to form holo cyt b562 ZnPP.
Biophysical analysis of cyt b562 variants UV-Vis Spectrophotometry and porphyrin titration
The absorbance spectra were monitored using Cary UV-Vis Spectrophotometer. The porphyrin titration experiments were performed using 20 μM apo-cyt b562 in 1ml of 10 mM phosphate buffer pH 6.2 with either 10 μM ferricyanide (for oxidised spectra) or 10 μM ascorbic acid (for reduced spectra). Either hemin (20 µM stock) or ZnPP (20 µM stock) were titrated against the protein solution. Apo-cyt b562 concentration was determined by measuring the absorbance at 280 nm (molar absorbance coefficient 2.98 mM -1 cm -1 ) and the holo-cyt b562 concentration was determined by monitoring 430 nm for ZnPP titration and 418 nm for oxidised hemin or 428 nm for reduced hemin. The resultant titration curves were then fitted to determine dissociation constant (see Figure S3 for examples), as described previously 20 .
Fluorescence Spectroscopy Excitation and emission spectra were recorded using a Varian Cary Eclipse spectrophotometer and the corresponding Cary Eclipse software. Samples of 750 μL comprising of 2.5-10 μΜ protein/porphyrin were analysed in a 5 × 5 mm QS quartz cuvette (Hellma, Müllheim, Germany). Spectra were recorded at a scan rate of either 120 or 600 nm/min with a slit width of 5 nm. Emission spectra were recorded up to 700 nm from a fixed excitation wavelength (corresponding to lMAX from the absorbance spectrum [~430 nm and ~590 nm] with an associated emission peak) for each variant. Quantum Yield studies were carried out using Alexa Fluor 431, essentially as described previously [53] [54] . For the in vivo analysis, liquid cell cultures were grown at 37℃ to an A600 of 0.6. The cells were pelleted by centrifugation in a microfuge for 20 min at 4°C. ZnPP (20 μM) in 10 mM Tris-HCl (pH 8.0) was used to resuspended the cell pellet. A cell culture without the plasmid encoding the cyt b562 variants was used as a control. Fluorescence readings were taken periodically to determine rate of ZnPP uptake and incorporation.
Red edge excitation spectra (REES) analysis All fluorescence measurements were performed using a Varian Cary Eclipse fluorescence spectrophotometer (Agilent Technologies) with a 5×5mm QS quartz cuvette (Hellma UK). The fluorimeter was baselined with 10mM sodium phosphate buffer (pH6.2) and all measurements were taken at 20°C. Excitation and emission slit widths were 5 nm and a scan rate of 600 or 120nm/min was used. Samples were incubated for 30 minutes at the given conditions prior to recording measurements. The red edge excitation scans were monitored from 413 to 437 nm with increments of 2 nm in the excitation wavelength. The wavelength of maximum emission, was extracted from the emission spectra by fitting to a sum (two) of skewed Gaussians of the form:
Eq 1
Where FI is the measured fluorescence intensity at an emission wavelength, λEM. The spectra are then characterised by the amplitude, A of the spectrum at the maximum of fluorescence intensity, λEM max , spectral width at half maximal, w and the minimum of the fluorescence emission, FI0, which was ~ zero for the buffer subtracted spectra. CD spectroscopy Circular dichroism spectroscopy was performed on a Jasco J-710 as described previously 20 . 40 ; b determined previously 20 ; c affinity too tight to measure accurately by current approach so a upper estimate is given; d affinity too weak to measure. S1 . Cytochrome b562 structure. The protein is shown as green cartoon with haem shown in the stick representation and coloured cyan; the Fe centre is coloured brown. On the right hand side, the residues targeted for mutagenesis in helix H1 are shown. Fig S3. Binding affinity for haem and ZnPP. (a) cyt b562 ZnPP (red) and wt cyt b562 haem binding capacity. Protein (5 µM) was incubated with 6 µM haem and binding monitored. The free haem spectrum (dashed black lines) is shown for reference. Less than 10% haem binding to cyt b562 ZnPP was observed. (b) Haem and (c) ZnPP titration curves. The wild-type cyt b562 (black line, circles), cyt b562 M7C (blue line, diamonds) cyt b562 ZnPP (red) are shown. The data is based on triplicate reading (errors bars are removed for clarity). The data was fit and the KD was calculated using a previously described approach 20, 30 . Figure S4 . Model of the cyt b562 ZnPP50 binding pocket. The potential interaction between the introduced guanidinium group of R10 and the new thiol group that can coordinate Zn 2+ is shown as a red dashed line. 
